nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—RRM1—lung cancer	0.437	1	CbGaD
Hydroxyurea—RRM1—Gemcitabine—lung cancer	0.17	0.454	CbGbCtD
Hydroxyurea—RRM2—Gemcitabine—lung cancer	0.17	0.454	CbGbCtD
Hydroxyurea—CYP2D6—Gefitinib—lung cancer	0.0109	0.0292	CbGbCtD
Hydroxyurea—CYP2D6—Vinorelbine—lung cancer	0.0084	0.0225	CbGbCtD
Hydroxyurea—CYP2D6—Erlotinib—lung cancer	0.00645	0.0173	CbGbCtD
Hydroxyurea—CYP2D6—Vinblastine—lung cancer	0.00518	0.0139	CbGbCtD
Hydroxyurea—CYP2D6—Doxorubicin—lung cancer	0.00318	0.00852	CbGbCtD
Hydroxyurea—RRM2—mammary gland—lung cancer	0.00249	0.16	CbGeAlD
Hydroxyurea—RRM1—mammary gland—lung cancer	0.00207	0.133	CbGeAlD
Hydroxyurea—RRM2—respiratory system—lung cancer	0.00166	0.107	CbGeAlD
Hydroxyurea—RRM1—respiratory system—lung cancer	0.00138	0.0887	CbGeAlD
Hydroxyurea—RRM2—bronchus—lung cancer	0.00137	0.0878	CbGeAlD
Hydroxyurea—RRM1—bronchus—lung cancer	0.00113	0.073	CbGeAlD
Hydroxyurea—RRM2—bone marrow—lung cancer	0.000972	0.0625	CbGeAlD
Hydroxyurea—RRM1—cardiac atrium—lung cancer	0.000957	0.0615	CbGeAlD
Hydroxyurea—RRM2—lung—lung cancer	0.000881	0.0567	CbGeAlD
Hydroxyurea—RRM1—bone marrow—lung cancer	0.000808	0.052	CbGeAlD
Hydroxyurea—RRM1—lung—lung cancer	0.000732	0.0471	CbGeAlD
Hydroxyurea—RRM2—Afatinib—Gefitinib—lung cancer	0.000727	0.301	CbGdCrCtD
Hydroxyurea—RRM2—Gefitinib—Erlotinib—lung cancer	0.000713	0.295	CbGdCrCtD
Hydroxyurea—RRM2—lymph node—lung cancer	0.000602	0.0388	CbGeAlD
Hydroxyurea—RRM1—lymph node—lung cancer	0.0005	0.0322	CbGeAlD
Hydroxyurea—RRM2—Vinorelbine—Vinblastine—lung cancer	0.000478	0.198	CbGdCrCtD
Hydroxyurea—RRM1—Azacitidine—Gemcitabine—lung cancer	0.000307	0.127	CbGdCrCtD
Hydroxyurea—RRM2—Azacitidine—Gemcitabine—lung cancer	0.000193	0.0796	CbGdCrCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	9.63e-05	0.00191	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN2A—lung cancer	9.6e-05	0.00191	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—PPP2R1B—lung cancer	9.4e-05	0.00187	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—CDKN1A—lung cancer	9.31e-05	0.00185	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ATP5H—lung cancer	9.3e-05	0.00185	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—MYC—lung cancer	9.25e-05	0.00184	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—TP53—lung cancer	9.22e-05	0.00183	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—HSD17B10—lung cancer	9.21e-05	0.00183	CbGpPWpGaD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	9.01e-05	0.00179	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—LMNA—lung cancer	8.96e-05	0.00178	CbGpPWpGaD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP2A6—lung cancer	8.89e-05	0.00177	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	8.57e-05	0.0017	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CKB—lung cancer	8.56e-05	0.0017	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	8.54e-05	0.0017	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	8.45e-05	0.00168	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—PPP2R1B—lung cancer	8.4e-05	0.00167	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PLBD1—lung cancer	8.29e-05	0.00165	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	8.26e-05	0.00164	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CCND1—lung cancer	8.11e-05	0.00161	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTM2—lung cancer	8.05e-05	0.0016	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CNDP2—lung cancer	8.05e-05	0.0016	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—LMNA—lung cancer	8.02e-05	0.00159	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN1A—lung cancer	7.85e-05	0.00156	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—MTMR3—lung cancer	7.83e-05	0.00156	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—MYC—lung cancer	7.72e-05	0.00153	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	7.67e-05	0.00152	CbGpPWpGaD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	7.66e-05	0.00152	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PGAM1—lung cancer	7.63e-05	0.00152	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—TP53—lung cancer	7.6e-05	0.00151	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—HSD17B10—lung cancer	7.58e-05	0.00151	CbGpPWpGaD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—lung cancer	7.56e-05	0.0015	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	7.46e-05	0.00148	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	7.45e-05	0.00148	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CNDP2—lung cancer	7.39e-05	0.00147	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTM2—lung cancer	7.39e-05	0.00147	CbGpPWpGaD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	7.3e-05	0.00145	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTM2—lung cancer	7.28e-05	0.00145	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP2A7—lung cancer	7.28e-05	0.00145	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	7.22e-05	0.00143	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	7.2e-05	0.00143	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—SDC4—lung cancer	7.12e-05	0.00142	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CKB—lung cancer	7.05e-05	0.0014	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	6.87e-05	0.00137	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	6.68e-05	0.00133	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP2A7—lung cancer	6.68e-05	0.00133	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTM2—lung cancer	6.63e-05	0.00132	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CNDP2—lung cancer	6.63e-05	0.00132	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP2A7—lung cancer	6.59e-05	0.00131	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—MYC—lung cancer	6.51e-05	0.00129	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	6.51e-05	0.00129	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTA3—lung cancer	6.49e-05	0.00129	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—MTMR3—lung cancer	6.45e-05	0.00128	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PGAM1—lung cancer	6.28e-05	0.00125	CbGpPWpGaD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	6.21e-05	0.00123	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	6.16e-05	0.00122	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—B4GALT5—lung cancer	6.1e-05	0.00121	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP2A7—lung cancer	6e-05	0.00119	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	5.99e-05	0.00119	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTA3—lung cancer	5.95e-05	0.00118	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTA4—lung cancer	5.94e-05	0.00118	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—TYMS—lung cancer	5.91e-05	0.00117	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTA3—lung cancer	5.87e-05	0.00117	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—SDC4—lung cancer	5.87e-05	0.00117	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	5.86e-05	0.00116	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTA2—lung cancer	5.78e-05	0.00115	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTA1—lung cancer	5.58e-05	0.00111	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	5.53e-05	0.0011	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ABCC3—lung cancer	5.52e-05	0.0011	CbGpPWpGaD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	5.5e-05	0.00109	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTA4—lung cancer	5.45e-05	0.00108	CbGpPWpGaD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—lung cancer	5.43e-05	0.00108	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTA4—lung cancer	5.37e-05	0.00107	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—AKR1C1—lung cancer	5.34e-05	0.00106	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—RRM1—lung cancer	5.34e-05	0.00106	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTA3—lung cancer	5.34e-05	0.00106	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—BIRC5—lung cancer	5.31e-05	0.00106	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTA2—lung cancer	5.31e-05	0.00105	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—TYMS—lung cancer	5.28e-05	0.00105	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Irinotecan—lung cancer	5.2e-05	0.00043	CcSEcCtD
Hydroxyurea—Nervous system disorder—Cisplatin—lung cancer	5.19e-05	0.000429	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—UGT1A1—lung cancer	5.19e-05	0.00103	CbGpPWpGaD
Hydroxyurea—Somnolence—Irinotecan—lung cancer	5.19e-05	0.000429	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Cisplatin—lung cancer	5.19e-05	0.000429	CcSEcCtD
Hydroxyurea—Headache—Topotecan—lung cancer	5.18e-05	0.000428	CcSEcCtD
Hydroxyurea—Rash—Erlotinib—lung cancer	5.16e-05	0.000426	CcSEcCtD
Hydroxyurea—Dermatitis—Erlotinib—lung cancer	5.15e-05	0.000426	CcSEcCtD
Hydroxyurea—Convulsion—Etoposide—lung cancer	5.15e-05	0.000426	CcSEcCtD
Hydroxyurea—Angiopathy—Docetaxel—lung cancer	5.15e-05	0.000426	CcSEcCtD
Hydroxyurea—Skin disorder—Cisplatin—lung cancer	5.14e-05	0.000425	CcSEcCtD
Hydroxyurea—Dyspepsia—Irinotecan—lung cancer	5.14e-05	0.000424	CcSEcCtD
Hydroxyurea—Headache—Erlotinib—lung cancer	5.13e-05	0.000424	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—GSTA1—lung cancer	5.12e-05	0.00102	CbGpPWpGaD
Hydroxyurea—Chills—Docetaxel—lung cancer	5.09e-05	0.000421	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	5.08e-05	0.00101	CbGpPWpGaD
Hydroxyurea—Asthenia—Vinorelbine—lung cancer	5.07e-05	0.000419	CcSEcCtD
Hydroxyurea—Decreased appetite—Irinotecan—lung cancer	5.07e-05	0.000419	CcSEcCtD
Hydroxyurea—Dyspnoea—Gemcitabine—lung cancer	5.07e-05	0.000419	CcSEcCtD
Hydroxyurea—Nausea—Vinblastine—lung cancer	5.06e-05	0.000418	CcSEcCtD
Hydroxyurea—Somnolence—Gemcitabine—lung cancer	5.05e-05	0.000418	CcSEcCtD
Hydroxyurea—Convulsion—Paclitaxel—lung cancer	5.05e-05	0.000417	CcSEcCtD
Hydroxyurea—Anorexia—Cisplatin—lung cancer	5.05e-05	0.000417	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Irinotecan—lung cancer	5.04e-05	0.000416	CcSEcCtD
Hydroxyurea—Fatigue—Irinotecan—lung cancer	5.03e-05	0.000416	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	5.03e-05	0.000415	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—B4GALT5—lung cancer	5.02e-05	0.000998	CbGpPWpGaD
Hydroxyurea—Alopecia—Docetaxel—lung cancer	5.02e-05	0.000415	CcSEcCtD
Hydroxyurea—Pancreatitis—Methotrexate—lung cancer	5.01e-05	0.000414	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—GNG11—lung cancer	5e-05	0.000994	CbGpPWpGaD
Hydroxyurea—Discomfort—Etoposide—lung cancer	5e-05	0.000413	CcSEcCtD
Hydroxyurea—Pain—Irinotecan—lung cancer	4.99e-05	0.000412	CcSEcCtD
Hydroxyurea—Constipation—Irinotecan—lung cancer	4.99e-05	0.000412	CcSEcCtD
Hydroxyurea—Face oedema—Doxorubicin—lung cancer	4.94e-05	0.000409	CcSEcCtD
Hydroxyurea—Erythema—Docetaxel—lung cancer	4.94e-05	0.000408	CcSEcCtD
Hydroxyurea—Decreased appetite—Gemcitabine—lung cancer	4.94e-05	0.000408	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	4.93e-05	0.000407	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	4.92e-05	0.000977	CbGpPWpGaD
Hydroxyurea—Nausea—Topotecan—lung cancer	4.91e-05	0.000406	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Gemcitabine—lung cancer	4.91e-05	0.000405	CcSEcCtD
Hydroxyurea—Discomfort—Paclitaxel—lung cancer	4.9e-05	0.000405	CcSEcCtD
Hydroxyurea—Fatigue—Gemcitabine—lung cancer	4.9e-05	0.000405	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—GSTA4—lung cancer	4.89e-05	0.000971	CbGpPWpGaD
Hydroxyurea—Constipation—Gemcitabine—lung cancer	4.86e-05	0.000402	CcSEcCtD
Hydroxyurea—Pain—Gemcitabine—lung cancer	4.86e-05	0.000402	CcSEcCtD
Hydroxyurea—Nausea—Erlotinib—lung cancer	4.86e-05	0.000402	CcSEcCtD
Hydroxyurea—Pancytopenia—Methotrexate—lung cancer	4.85e-05	0.000401	CcSEcCtD
Hydroxyurea—Diarrhoea—Vinorelbine—lung cancer	4.84e-05	0.0004	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—AKR1C1—lung cancer	4.84e-05	0.000961	CbGpPWpGaD
Hydroxyurea—Infection—Etoposide—lung cancer	4.82e-05	0.000398	CcSEcCtD
Hydroxyurea—Feeling abnormal—Irinotecan—lung cancer	4.81e-05	0.000397	CcSEcCtD
Hydroxyurea—Blood creatinine increased—Doxorubicin—lung cancer	4.8e-05	0.000396	CcSEcCtD
Hydroxyurea—Dysuria—Methotrexate—lung cancer	4.78e-05	0.000395	CcSEcCtD
Hydroxyurea—Neutropenia—Methotrexate—lung cancer	4.78e-05	0.000395	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—ALDOA—lung cancer	4.76e-05	0.000947	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTA2—lung cancer	4.76e-05	0.000947	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—UGT1A1—lung cancer	4.76e-05	0.000946	CbGpPWpGaD
Hydroxyurea—Oedema—Paclitaxel—lung cancer	4.76e-05	0.000393	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—BIRC5—lung cancer	4.75e-05	0.000944	CbGpPWpGaD
Hydroxyurea—Thrombocytopenia—Etoposide—lung cancer	4.75e-05	0.000393	CcSEcCtD
Hydroxyurea—Infection—Paclitaxel—lung cancer	4.73e-05	0.000391	CcSEcCtD
Hydroxyurea—Dyspnoea—Cisplatin—lung cancer	4.72e-05	0.00039	CcSEcCtD
Hydroxyurea—Skin disorder—Etoposide—lung cancer	4.71e-05	0.00039	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—UGT1A1—lung cancer	4.69e-05	0.000933	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Gemcitabine—lung cancer	4.68e-05	0.000387	CcSEcCtD
Hydroxyurea—Dizziness—Vinorelbine—lung cancer	4.68e-05	0.000387	CcSEcCtD
Hydroxyurea—Nervous system disorder—Paclitaxel—lung cancer	4.67e-05	0.000386	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Paclitaxel—lung cancer	4.66e-05	0.000385	CcSEcCtD
Hydroxyurea—Breast disorder—Doxorubicin—lung cancer	4.63e-05	0.000382	CcSEcCtD
Hydroxyurea—Anorexia—Etoposide—lung cancer	4.63e-05	0.000382	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—NCOA3—lung cancer	4.62e-05	0.000919	CbGpPWpGaD
Hydroxyurea—Skin disorder—Paclitaxel—lung cancer	4.62e-05	0.000382	CcSEcCtD
Hydroxyurea—Body temperature increased—Irinotecan—lung cancer	4.61e-05	0.000381	CcSEcCtD
Hydroxyurea—Decreased appetite—Cisplatin—lung cancer	4.6e-05	0.000381	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—TERT—lung cancer	4.6e-05	0.000915	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTA1—lung cancer	4.6e-05	0.000913	CbGpPWpGaD
Hydroxyurea—Gastrointestinal disorder—Cisplatin—lung cancer	4.57e-05	0.000378	CcSEcCtD
Hydroxyurea—Anaemia—Docetaxel—lung cancer	4.57e-05	0.000377	CcSEcCtD
Hydroxyurea—Infestation NOS—Methotrexate—lung cancer	4.56e-05	0.000377	CcSEcCtD
Hydroxyurea—Drowsiness—Methotrexate—lung cancer	4.56e-05	0.000377	CcSEcCtD
Hydroxyurea—Infestation—Methotrexate—lung cancer	4.56e-05	0.000377	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—ABCC3—lung cancer	4.54e-05	0.000903	CbGpPWpGaD
Hydroxyurea—Anorexia—Paclitaxel—lung cancer	4.54e-05	0.000375	CcSEcCtD
Hydroxyurea—Pain—Cisplatin—lung cancer	4.53e-05	0.000374	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—ABCG2—lung cancer	4.5e-05	0.000894	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ADCY1—lung cancer	4.5e-05	0.000894	CbGpPWpGaD
Hydroxyurea—Vomiting—Vinorelbine—lung cancer	4.5e-05	0.000372	CcSEcCtD
Hydroxyurea—Body temperature increased—Gemcitabine—lung cancer	4.49e-05	0.000371	CcSEcCtD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	4.46e-05	0.000887	CbGpPWpGaD
Hydroxyurea—Rash—Vinorelbine—lung cancer	4.46e-05	0.000369	CcSEcCtD
Hydroxyurea—Dermatitis—Vinorelbine—lung cancer	4.46e-05	0.000368	CcSEcCtD
Hydroxyurea—Stomatitis—Methotrexate—lung cancer	4.44e-05	0.000367	CcSEcCtD
Hydroxyurea—Headache—Vinorelbine—lung cancer	4.43e-05	0.000366	CcSEcCtD
Hydroxyurea—Leukopenia—Docetaxel—lung cancer	4.42e-05	0.000366	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—HPGDS—lung cancer	4.41e-05	0.000877	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ENO2—lung cancer	4.41e-05	0.000877	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—AKR1C1—lung cancer	4.4e-05	0.000875	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PPP2R1B—lung cancer	4.38e-05	0.000871	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Cisplatin—lung cancer	4.36e-05	0.000361	CcSEcCtD
Hydroxyurea—Pancreatitis—Doxorubicin—lung cancer	4.34e-05	0.000359	CcSEcCtD
Hydroxyurea—Dyspnoea—Etoposide—lung cancer	4.33e-05	0.000358	CcSEcCtD
Hydroxyurea—Somnolence—Etoposide—lung cancer	4.31e-05	0.000357	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Methotrexate—lung cancer	4.31e-05	0.000356	CcSEcCtD
Hydroxyurea—Hypersensitivity—Irinotecan—lung cancer	4.3e-05	0.000355	CcSEcCtD
Hydroxyurea—Convulsion—Docetaxel—lung cancer	4.28e-05	0.000354	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—GSTT1—lung cancer	4.28e-05	0.00085	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—UGT1A1—lung cancer	4.27e-05	0.000849	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Paclitaxel—lung cancer	4.24e-05	0.000351	CcSEcCtD
Hydroxyurea—Somnolence—Paclitaxel—lung cancer	4.23e-05	0.00035	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CYP2A6—lung cancer	4.23e-05	0.00084	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GCLC—lung cancer	4.23e-05	0.00084	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Etoposide—lung cancer	4.22e-05	0.000349	CcSEcCtD
Hydroxyurea—Pancytopenia—Doxorubicin—lung cancer	4.2e-05	0.000347	CcSEcCtD
Hydroxyurea—Nausea—Vinorelbine—lung cancer	4.2e-05	0.000347	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Etoposide—lung cancer	4.19e-05	0.000346	CcSEcCtD
Hydroxyurea—Dyspepsia—Paclitaxel—lung cancer	4.19e-05	0.000346	CcSEcCtD
Hydroxyurea—Body temperature increased—Cisplatin—lung cancer	4.19e-05	0.000346	CcSEcCtD
Hydroxyurea—Asthenia—Irinotecan—lung cancer	4.19e-05	0.000346	CcSEcCtD
Hydroxyurea—Fatigue—Etoposide—lung cancer	4.18e-05	0.000346	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	4.18e-05	0.000345	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	4.15e-05	0.000825	CbGpPWpGaD
Hydroxyurea—Pain—Etoposide—lung cancer	4.15e-05	0.000343	CcSEcCtD
Hydroxyurea—Constipation—Etoposide—lung cancer	4.15e-05	0.000343	CcSEcCtD
Hydroxyurea—Dysuria—Doxorubicin—lung cancer	4.14e-05	0.000342	CcSEcCtD
Hydroxyurea—Neutropenia—Doxorubicin—lung cancer	4.14e-05	0.000342	CcSEcCtD
Hydroxyurea—Decreased appetite—Paclitaxel—lung cancer	4.14e-05	0.000342	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—GNG11—lung cancer	4.12e-05	0.000819	CbGpPWpGaD
Hydroxyurea—Haemoglobin—Methotrexate—lung cancer	4.11e-05	0.00034	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Paclitaxel—lung cancer	4.11e-05	0.000339	CcSEcCtD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	4.1e-05	0.000816	CbGpPWpGaD
Hydroxyurea—Fatigue—Paclitaxel—lung cancer	4.1e-05	0.000339	CcSEcCtD
Hydroxyurea—Haemorrhage—Methotrexate—lung cancer	4.09e-05	0.000338	CcSEcCtD
Hydroxyurea—Asthenia—Gemcitabine—lung cancer	4.08e-05	0.000337	CcSEcCtD
Hydroxyurea—Pain—Paclitaxel—lung cancer	4.07e-05	0.000336	CcSEcCtD
Hydroxyurea—Constipation—Paclitaxel—lung cancer	4.07e-05	0.000336	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—HPGDS—lung cancer	4.05e-05	0.000804	CbGpPWpGaD
Hydroxyurea—Oedema—Docetaxel—lung cancer	4.03e-05	0.000333	CcSEcCtD
Hydroxyurea—Weight increased—Doxorubicin—lung cancer	4.03e-05	0.000333	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—ENO1—lung cancer	4.01e-05	0.000797	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—RB1—lung cancer	4.01e-05	0.000796	CbGpPWpGaD
Hydroxyurea—Infection—Docetaxel—lung cancer	4.01e-05	0.000331	CcSEcCtD
Hydroxyurea—Feeling abnormal—Etoposide—lung cancer	4e-05	0.00033	CcSEcCtD
Hydroxyurea—Diarrhoea—Irinotecan—lung cancer	3.99e-05	0.00033	CcSEcCtD
Hydroxyurea—Nervous system disorder—Docetaxel—lung cancer	3.95e-05	0.000327	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Docetaxel—lung cancer	3.95e-05	0.000326	CcSEcCtD
Hydroxyurea—Drowsiness—Doxorubicin—lung cancer	3.95e-05	0.000326	CcSEcCtD
Hydroxyurea—Infestation NOS—Doxorubicin—lung cancer	3.95e-05	0.000326	CcSEcCtD
Hydroxyurea—Infestation—Doxorubicin—lung cancer	3.95e-05	0.000326	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—GSTT1—lung cancer	3.93e-05	0.00078	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ALDOA—lung cancer	3.92e-05	0.000779	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Paclitaxel—lung cancer	3.92e-05	0.000324	CcSEcCtD
Hydroxyurea—Skin disorder—Docetaxel—lung cancer	3.92e-05	0.000324	CcSEcCtD
Hydroxyurea—Hypersensitivity—Cisplatin—lung cancer	3.9e-05	0.000323	CcSEcCtD
Hydroxyurea—Diarrhoea—Gemcitabine—lung cancer	3.89e-05	0.000321	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—GCLC—lung cancer	3.88e-05	0.000771	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP2A6—lung cancer	3.88e-05	0.000771	CbGpPWpGaD
Hydroxyurea—Neuropathy peripheral—Doxorubicin—lung cancer	3.87e-05	0.00032	CcSEcCtD
Hydroxyurea—Dizziness—Irinotecan—lung cancer	3.86e-05	0.000319	CcSEcCtD
Hydroxyurea—Stomatitis—Doxorubicin—lung cancer	3.85e-05	0.000318	CcSEcCtD
Hydroxyurea—Anorexia—Docetaxel—lung cancer	3.84e-05	0.000318	CcSEcCtD
Hydroxyurea—Body temperature increased—Etoposide—lung cancer	3.84e-05	0.000317	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—NCOA3—lung cancer	3.81e-05	0.000757	CbGpPWpGaD
Hydroxyurea—Asthenia—Cisplatin—lung cancer	3.8e-05	0.000314	CcSEcCtD
Hydroxyurea—Body temperature increased—Paclitaxel—lung cancer	3.76e-05	0.000311	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Doxorubicin—lung cancer	3.73e-05	0.000308	CcSEcCtD
Hydroxyurea—Angiopathy—Methotrexate—lung cancer	3.71e-05	0.000307	CcSEcCtD
Hydroxyurea—Vomiting—Irinotecan—lung cancer	3.71e-05	0.000307	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—ADCY1—lung cancer	3.7e-05	0.000736	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ABCG2—lung cancer	3.7e-05	0.000736	CbGpPWpGaD
Hydroxyurea—Rash—Irinotecan—lung cancer	3.68e-05	0.000304	CcSEcCtD
Hydroxyurea—Dermatitis—Irinotecan—lung cancer	3.67e-05	0.000304	CcSEcCtD
Hydroxyurea—Chills—Methotrexate—lung cancer	3.67e-05	0.000303	CcSEcCtD
Hydroxyurea—Headache—Irinotecan—lung cancer	3.65e-05	0.000302	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—HPGDS—lung cancer	3.63e-05	0.000722	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ENO2—lung cancer	3.63e-05	0.000722	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Cisplatin—lung cancer	3.62e-05	0.0003	CcSEcCtD
Hydroxyurea—Alopecia—Methotrexate—lung cancer	3.62e-05	0.000299	CcSEcCtD
Hydroxyurea—Vomiting—Gemcitabine—lung cancer	3.61e-05	0.000299	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—PPP2R1B—lung cancer	3.61e-05	0.000717	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP2E1—lung cancer	3.6e-05	0.000715	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Docetaxel—lung cancer	3.6e-05	0.000297	CcSEcCtD
Hydroxyurea—Somnolence—Docetaxel—lung cancer	3.58e-05	0.000296	CcSEcCtD
Hydroxyurea—Rash—Gemcitabine—lung cancer	3.58e-05	0.000296	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—RB1—lung cancer	3.58e-05	0.000712	CbGpPWpGaD
Hydroxyurea—Dermatitis—Gemcitabine—lung cancer	3.58e-05	0.000296	CcSEcCtD
Hydroxyurea—Hypersensitivity—Etoposide—lung cancer	3.58e-05	0.000295	CcSEcCtD
Hydroxyurea—Erythema—Methotrexate—lung cancer	3.56e-05	0.000294	CcSEcCtD
Hydroxyurea—Haemoglobin—Doxorubicin—lung cancer	3.56e-05	0.000294	CcSEcCtD
Hydroxyurea—Headache—Gemcitabine—lung cancer	3.56e-05	0.000294	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—NQO1—lung cancer	3.56e-05	0.000707	CbGpPWpGaD
Hydroxyurea—Dyspepsia—Docetaxel—lung cancer	3.55e-05	0.000293	CcSEcCtD
Hydroxyurea—Haemorrhage—Doxorubicin—lung cancer	3.54e-05	0.000293	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—GSTT1—lung cancer	3.52e-05	0.0007	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN2A—lung cancer	3.52e-05	0.0007	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Docetaxel—lung cancer	3.51e-05	0.00029	CcSEcCtD
Hydroxyurea—Hypersensitivity—Paclitaxel—lung cancer	3.51e-05	0.00029	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—CYP2A6—lung cancer	3.48e-05	0.000692	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GCLC—lung cancer	3.48e-05	0.000692	CbGpPWpGaD
Hydroxyurea—Gastrointestinal disorder—Docetaxel—lung cancer	3.48e-05	0.000288	CcSEcCtD
Hydroxyurea—Asthenia—Etoposide—lung cancer	3.48e-05	0.000288	CcSEcCtD
Hydroxyurea—Fatigue—Docetaxel—lung cancer	3.48e-05	0.000287	CcSEcCtD
Hydroxyurea—Nausea—Irinotecan—lung cancer	3.47e-05	0.000286	CcSEcCtD
Hydroxyurea—Constipation—Docetaxel—lung cancer	3.45e-05	0.000285	CcSEcCtD
Hydroxyurea—Pain—Docetaxel—lung cancer	3.45e-05	0.000285	CcSEcCtD
Hydroxyurea—Asthenia—Paclitaxel—lung cancer	3.41e-05	0.000282	CcSEcCtD
Hydroxyurea—Nausea—Gemcitabine—lung cancer	3.38e-05	0.000279	CcSEcCtD
Hydroxyurea—Vomiting—Cisplatin—lung cancer	3.37e-05	0.000278	CcSEcCtD
Hydroxyurea—Rash—Cisplatin—lung cancer	3.34e-05	0.000276	CcSEcCtD
Hydroxyurea—Dermatitis—Cisplatin—lung cancer	3.34e-05	0.000276	CcSEcCtD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—POMC—lung cancer	3.33e-05	0.000661	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Docetaxel—lung cancer	3.32e-05	0.000275	CcSEcCtD
Hydroxyurea—Diarrhoea—Etoposide—lung cancer	3.32e-05	0.000274	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Methotrexate—lung cancer	3.3e-05	0.000273	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—ENO1—lung cancer	3.3e-05	0.000656	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP2E1—lung cancer	3.3e-05	0.000656	CbGpPWpGaD
Hydroxyurea—Anaemia—Methotrexate—lung cancer	3.29e-05	0.000272	CcSEcCtD
Hydroxyurea—Diarrhoea—Paclitaxel—lung cancer	3.26e-05	0.000269	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP2E1—lung cancer	3.25e-05	0.000647	CbGpPWpGaD
Hydroxyurea—Angiopathy—Doxorubicin—lung cancer	3.21e-05	0.000266	CcSEcCtD
Hydroxyurea—Malaise—Methotrexate—lung cancer	3.21e-05	0.000265	CcSEcCtD
Hydroxyurea—Dizziness—Etoposide—lung cancer	3.21e-05	0.000265	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—STK11—lung cancer	3.21e-05	0.000637	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Docetaxel—lung cancer	3.19e-05	0.000263	CcSEcCtD
Hydroxyurea—Leukopenia—Methotrexate—lung cancer	3.19e-05	0.000263	CcSEcCtD
Hydroxyurea—Chills—Doxorubicin—lung cancer	3.18e-05	0.000263	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CDKN2A—lung cancer	3.15e-05	0.000626	CbGpPWpGaD
Hydroxyurea—Dizziness—Paclitaxel—lung cancer	3.15e-05	0.00026	CcSEcCtD
Hydroxyurea—Nausea—Cisplatin—lung cancer	3.15e-05	0.00026	CcSEcCtD
Hydroxyurea—Alopecia—Doxorubicin—lung cancer	3.13e-05	0.000259	CcSEcCtD
Hydroxyurea—Convulsion—Methotrexate—lung cancer	3.09e-05	0.000255	CcSEcCtD
Hydroxyurea—Vomiting—Etoposide—lung cancer	3.09e-05	0.000255	CcSEcCtD
Hydroxyurea—Erythema—Doxorubicin—lung cancer	3.08e-05	0.000255	CcSEcCtD
Hydroxyurea—Rash—Etoposide—lung cancer	3.06e-05	0.000253	CcSEcCtD
Hydroxyurea—Dermatitis—Etoposide—lung cancer	3.06e-05	0.000253	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—MDM2—lung cancer	3.05e-05	0.000607	CbGpPWpGaD
Hydroxyurea—Headache—Etoposide—lung cancer	3.04e-05	0.000251	CcSEcCtD
Hydroxyurea—Vomiting—Paclitaxel—lung cancer	3.02e-05	0.00025	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	3.01e-05	0.000249	CcSEcCtD
Hydroxyurea—Rash—Paclitaxel—lung cancer	3e-05	0.000248	CcSEcCtD
Hydroxyurea—Dermatitis—Paclitaxel—lung cancer	3e-05	0.000248	CcSEcCtD
Hydroxyurea—Discomfort—Methotrexate—lung cancer	3e-05	0.000248	CcSEcCtD
Hydroxyurea—Headache—Paclitaxel—lung cancer	2.98e-05	0.000246	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CCND1—lung cancer	2.98e-05	0.000591	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Docetaxel—lung cancer	2.97e-05	0.000246	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—GSTP1—lung cancer	2.97e-05	0.000589	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP2E1—lung cancer	2.96e-05	0.000588	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NQO1—lung cancer	2.93e-05	0.000582	CbGpPWpGaD
Hydroxyurea—Asthenia—Docetaxel—lung cancer	2.89e-05	0.000239	CcSEcCtD
Hydroxyurea—Infection—Methotrexate—lung cancer	2.89e-05	0.000239	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CAT—lung cancer	2.89e-05	0.000573	CbGpPWpGaD
Hydroxyurea—Nausea—Etoposide—lung cancer	2.88e-05	0.000238	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN1A—lung cancer	2.88e-05	0.000572	CbGpPWpGaD
Hydroxyurea—Ill-defined disorder—Doxorubicin—lung cancer	2.86e-05	0.000236	CcSEcCtD
Hydroxyurea—Nervous system disorder—Methotrexate—lung cancer	2.85e-05	0.000236	CcSEcCtD
Hydroxyurea—Anaemia—Doxorubicin—lung cancer	2.85e-05	0.000236	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Methotrexate—lung cancer	2.85e-05	0.000235	CcSEcCtD
Hydroxyurea—Nausea—Paclitaxel—lung cancer	2.83e-05	0.000234	CcSEcCtD
Hydroxyurea—Skin disorder—Methotrexate—lung cancer	2.82e-05	0.000233	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—ABCB1—lung cancer	2.81e-05	0.000558	CbGpPWpGaD
Hydroxyurea—Malaise—Doxorubicin—lung cancer	2.78e-05	0.00023	CcSEcCtD
Hydroxyurea—Anorexia—Methotrexate—lung cancer	2.77e-05	0.000229	CcSEcCtD
Hydroxyurea—Leukopenia—Doxorubicin—lung cancer	2.76e-05	0.000228	CcSEcCtD
Hydroxyurea—Diarrhoea—Docetaxel—lung cancer	2.76e-05	0.000228	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—TYMS—lung cancer	2.76e-05	0.000548	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—EP300—lung cancer	2.74e-05	0.000544	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTM1—lung cancer	2.73e-05	0.000542	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTP1—lung cancer	2.72e-05	0.000541	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTP1—lung cancer	2.68e-05	0.000533	CbGpPWpGaD
Hydroxyurea—Convulsion—Doxorubicin—lung cancer	2.67e-05	0.000221	CcSEcCtD
Hydroxyurea—Dizziness—Docetaxel—lung cancer	2.67e-05	0.00022	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CCND1—lung cancer	2.66e-05	0.000529	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—STK11—lung cancer	2.64e-05	0.000524	CbGpPWpGaD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	2.61e-05	0.000215	CcSEcCtD
Hydroxyurea—Discomfort—Doxorubicin—lung cancer	2.59e-05	0.000214	CcSEcCtD
Hydroxyurea—Dyspnoea—Methotrexate—lung cancer	2.59e-05	0.000214	CcSEcCtD
Hydroxyurea—Somnolence—Methotrexate—lung cancer	2.58e-05	0.000214	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CYP1A1—lung cancer	2.58e-05	0.000513	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDKN1A—lung cancer	2.57e-05	0.000512	CbGpPWpGaD
Hydroxyurea—Vomiting—Docetaxel—lung cancer	2.56e-05	0.000212	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—ERCC2—lung cancer	2.56e-05	0.000509	CbGpPWpGaD
Hydroxyurea—Dyspepsia—Methotrexate—lung cancer	2.56e-05	0.000211	CcSEcCtD
Hydroxyurea—Rash—Docetaxel—lung cancer	2.54e-05	0.00021	CcSEcCtD
Hydroxyurea—Dermatitis—Docetaxel—lung cancer	2.54e-05	0.00021	CcSEcCtD
Hydroxyurea—Decreased appetite—Methotrexate—lung cancer	2.53e-05	0.000209	CcSEcCtD
Hydroxyurea—Headache—Docetaxel—lung cancer	2.53e-05	0.000209	CcSEcCtD
Hydroxyurea—Oedema—Doxorubicin—lung cancer	2.52e-05	0.000208	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Methotrexate—lung cancer	2.51e-05	0.000207	CcSEcCtD
Hydroxyurea—Fatigue—Methotrexate—lung cancer	2.51e-05	0.000207	CcSEcCtD
Hydroxyurea—Infection—Doxorubicin—lung cancer	2.5e-05	0.000207	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—GSTM1—lung cancer	2.5e-05	0.000497	CbGpPWpGaD
Hydroxyurea—Pain—Methotrexate—lung cancer	2.49e-05	0.000205	CcSEcCtD
Hydroxyurea—Nervous system disorder—Doxorubicin—lung cancer	2.47e-05	0.000204	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTM1—lung cancer	2.47e-05	0.00049	CbGpPWpGaD
Hydroxyurea—Thrombocytopenia—Doxorubicin—lung cancer	2.46e-05	0.000204	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MAPK3—lung cancer	2.45e-05	0.000488	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—EP300—lung cancer	2.45e-05	0.000487	CbGpPWpGaD
Hydroxyurea—Skin disorder—Doxorubicin—lung cancer	2.44e-05	0.000202	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—GSTP1—lung cancer	2.44e-05	0.000485	CbGpPWpGaD
Hydroxyurea—Anorexia—Doxorubicin—lung cancer	2.4e-05	0.000198	CcSEcCtD
Hydroxyurea—Nausea—Docetaxel—lung cancer	2.4e-05	0.000198	CcSEcCtD
Hydroxyurea—Feeling abnormal—Methotrexate—lung cancer	2.4e-05	0.000198	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MYC—lung cancer	2.39e-05	0.000474	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CAT—lung cancer	2.38e-05	0.000472	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP1A1—lung cancer	2.37e-05	0.000471	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP1A1—lung cancer	2.34e-05	0.000465	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ABCB1—lung cancer	2.31e-05	0.000459	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Methotrexate—lung cancer	2.3e-05	0.00019	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—TYMS—lung cancer	2.27e-05	0.000451	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTM1—lung cancer	2.24e-05	0.000446	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Doxorubicin—lung cancer	2.24e-05	0.000185	CcSEcCtD
Hydroxyurea—Somnolence—Doxorubicin—lung cancer	2.24e-05	0.000185	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—APOA1—lung cancer	2.22e-05	0.00044	CbGpPWpGaD
Hydroxyurea—Dyspepsia—Doxorubicin—lung cancer	2.22e-05	0.000183	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—MAPK3—lung cancer	2.19e-05	0.000436	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Doxorubicin—lung cancer	2.19e-05	0.000181	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Doxorubicin—lung cancer	2.17e-05	0.00018	CcSEcCtD
Hydroxyurea—Fatigue—Doxorubicin—lung cancer	2.17e-05	0.000179	CcSEcCtD
Hydroxyurea—Constipation—Doxorubicin—lung cancer	2.15e-05	0.000178	CcSEcCtD
Hydroxyurea—Pain—Doxorubicin—lung cancer	2.15e-05	0.000178	CcSEcCtD
Hydroxyurea—Hypersensitivity—Methotrexate—lung cancer	2.14e-05	0.000177	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—MYC—lung cancer	2.13e-05	0.000424	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP1A1—lung cancer	2.13e-05	0.000423	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ERCC2—lung cancer	2.11e-05	0.000419	CbGpPWpGaD
Hydroxyurea—Asthenia—Methotrexate—lung cancer	2.09e-05	0.000172	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—AZIN2—lung cancer	2.08e-05	0.000414	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—COL4A3BP—lung cancer	2.08e-05	0.000414	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Doxorubicin—lung cancer	2.07e-05	0.000171	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—PIK3CG—lung cancer	2.02e-05	0.000402	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Doxorubicin—lung cancer	1.99e-05	0.000164	CcSEcCtD
Hydroxyurea—Diarrhoea—Methotrexate—lung cancer	1.99e-05	0.000164	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—POMC—lung cancer	1.93e-05	0.000383	CbGpPWpGaD
Hydroxyurea—Dizziness—Methotrexate—lung cancer	1.92e-05	0.000159	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CREBBP—lung cancer	1.88e-05	0.000373	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Doxorubicin—lung cancer	1.85e-05	0.000153	CcSEcCtD
Hydroxyurea—Vomiting—Methotrexate—lung cancer	1.85e-05	0.000153	CcSEcCtD
Hydroxyurea—Rash—Methotrexate—lung cancer	1.83e-05	0.000151	CcSEcCtD
Hydroxyurea—Dermatitis—Methotrexate—lung cancer	1.83e-05	0.000151	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—APOA1—lung cancer	1.83e-05	0.000363	CbGpPWpGaD
Hydroxyurea—Headache—Methotrexate—lung cancer	1.82e-05	0.00015	CcSEcCtD
Hydroxyurea—Asthenia—Doxorubicin—lung cancer	1.81e-05	0.000149	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—PIK3CD—lung cancer	1.78e-05	0.000354	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ATP5H—lung cancer	1.77e-05	0.000352	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—POMC—lung cancer	1.77e-05	0.000351	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ALB—lung cancer	1.76e-05	0.000349	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—TP53—lung cancer	1.75e-05	0.000348	CbGpPWpGaD
Hydroxyurea—Nausea—Methotrexate—lung cancer	1.73e-05	0.000143	CcSEcCtD
Hydroxyurea—Diarrhoea—Doxorubicin—lung cancer	1.72e-05	0.000142	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—PIK3CG—lung cancer	1.67e-05	0.000331	CbGpPWpGaD
Hydroxyurea—Dizziness—Doxorubicin—lung cancer	1.66e-05	0.000138	CcSEcCtD
Hydroxyurea—Vomiting—Doxorubicin—lung cancer	1.6e-05	0.000132	CcSEcCtD
Hydroxyurea—Rash—Doxorubicin—lung cancer	1.59e-05	0.000131	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—POMC—lung cancer	1.59e-05	0.000315	CbGpPWpGaD
Hydroxyurea—Dermatitis—Doxorubicin—lung cancer	1.59e-05	0.000131	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—PLBD1—lung cancer	1.58e-05	0.000314	CbGpPWpGaD
Hydroxyurea—Headache—Doxorubicin—lung cancer	1.58e-05	0.00013	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—PIK3CB—lung cancer	1.55e-05	0.000308	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CREBBP—lung cancer	1.54e-05	0.000307	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PTGS2—lung cancer	1.54e-05	0.000305	CbGpPWpGaD
Hydroxyurea—Nausea—Doxorubicin—lung cancer	1.49e-05	0.000124	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—PIK3CD—lung cancer	1.46e-05	0.000291	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ALB—lung cancer	1.45e-05	0.000287	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HSD17B10—lung cancer	1.45e-05	0.000287	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CKB—lung cancer	1.34e-05	0.000267	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PTEN—lung cancer	1.34e-05	0.000266	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—EP300—lung cancer	1.28e-05	0.000254	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CB—lung cancer	1.28e-05	0.000254	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PTGS2—lung cancer	1.27e-05	0.000251	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTM2—lung cancer	1.26e-05	0.000251	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CNDP2—lung cancer	1.26e-05	0.000251	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—MTMR3—lung cancer	1.23e-05	0.000244	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PGAM1—lung cancer	1.2e-05	0.000238	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP2A7—lung cancer	1.14e-05	0.000227	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SDC4—lung cancer	1.12e-05	0.000222	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PTEN—lung cancer	1.1e-05	0.000219	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—EP300—lung cancer	1.05e-05	0.000209	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—RRM1—lung cancer	1.02e-05	0.000202	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTA3—lung cancer	1.02e-05	0.000202	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—B4GALT5—lung cancer	9.57e-06	0.00019	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PIK3CA—lung cancer	9.45e-06	0.000188	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTA4—lung cancer	9.31e-06	0.000185	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTA2—lung cancer	9.07e-06	0.00018	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTA1—lung cancer	8.76e-06	0.000174	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ABCC3—lung cancer	8.66e-06	0.000172	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—AKR1C1—lung cancer	8.38e-06	0.000167	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—UGT1A1—lung cancer	8.14e-06	0.000162	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GNG11—lung cancer	7.85e-06	0.000156	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CA—lung cancer	7.78e-06	0.000155	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—AKT1—lung cancer	7.72e-06	0.000153	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ALDOA—lung cancer	7.47e-06	0.000149	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NCOA3—lung cancer	7.25e-06	0.000144	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ADCY1—lung cancer	7.06e-06	0.00014	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ABCG2—lung cancer	7.06e-06	0.00014	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HPGDS—lung cancer	6.92e-06	0.000138	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ENO2—lung cancer	6.92e-06	0.000138	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PPP2R1B—lung cancer	6.88e-06	0.000137	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTT1—lung cancer	6.71e-06	0.000133	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GCLC—lung cancer	6.64e-06	0.000132	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP2A6—lung cancer	6.64e-06	0.000132	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—AKT1—lung cancer	6.36e-06	0.000126	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ENO1—lung cancer	6.29e-06	0.000125	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP2E1—lung cancer	5.64e-06	0.000112	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NQO1—lung cancer	5.58e-06	0.000111	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—STK11—lung cancer	5.03e-06	9.99e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTP1—lung cancer	4.65e-06	9.25e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CAT—lung cancer	4.53e-06	9e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ABCB1—lung cancer	4.4e-06	8.75e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—TYMS—lung cancer	4.33e-06	8.6e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTM1—lung cancer	4.28e-06	8.5e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP1A1—lung cancer	4.05e-06	8.06e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ERCC2—lung cancer	4.02e-06	7.99e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—APOA1—lung cancer	3.48e-06	6.91e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CG—lung cancer	3.17e-06	6.31e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—POMC—lung cancer	3.02e-06	6.01e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CREBBP—lung cancer	2.94e-06	5.85e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CD—lung cancer	2.79e-06	5.55e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ALB—lung cancer	2.76e-06	5.48e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CB—lung cancer	2.43e-06	4.83e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PTGS2—lung cancer	2.41e-06	4.79e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PTEN—lung cancer	2.1e-06	4.18e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—EP300—lung cancer	2e-06	3.98e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CA—lung cancer	1.48e-06	2.95e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—AKT1—lung cancer	1.21e-06	2.41e-05	CbGpPWpGaD
